Table 2.
The link between GPX8 expression and clinicopathological characteristics (logistic regression).
| Clinical characteristics | Total (N) | Odds ratio in GPX8 expression | P-value |
|---|---|---|---|
| T classification (T1 vs. T2) | 99 | 14.00 (2.69–257.94) | 0.012 |
| T classification (T1vs. T3) | 187 | 21.27 (4.24–387.10) | 0.003 |
| T classification (T1 vs. T4) | 119 | 22.91 (4.46–420.12) | 0.003 |
| N classification (N0 vs. N1) | 208 | 1.77 (1.02–3.08) | 0.043 |
| N classification (N0 vs. N3) | 185 | 1.82 (1.01–3.32) | 0.048 |
| M classification (M0 vs. M1) | 355 | 1.87 (0.82–4.52) | 0.148 |
| Stage (I vs. II) | 164 | 3.62 (1.78–7.73) | 0.001 |
| Stage (I vs. IIII) | 203 | 3.33 (1.69–6.95) | 0.001 |
| Stage (I vs. IV) | 91 | 5.92 (2.42–15.29) | 0.000 |
| Age (<60 vs. ≥60) | 371 | 1.24 (0.79–1.93) | 0.348 |
| Grade (G1 vs. G2) | 147 | 0.78 (0.21–2.92) | 0.704 |
| Survival status (alive vs. dead) | 375 | 1.51 (0.98–2.31) | 0.061 |
| Race (no White vs. White) | 324 | 1.56 (0.95–2.58) | 0.079 |
| Residual (R0 vs. R2) | 329 | 2.38 (0.85–7.72) | 0.115 |
| Cancer status (tumor-free vs. with tumor) | 322 | 1.27 (0.76–2.13) | 0.361 |